SCIENTIFIC INDUSTRIES INC
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: March 31, 2025 | SCIENTIFIC INDUSTRIES, INC. |
|---|---|
| (Registrant) | |
| /s/ Helena R. Santos | |
| Helena R. Santos | |
| President, Chief Executive Officer, and Treasurer | |
| Date: March 31, 2025 | SCIENTIFIC INDUSTRIES, INC. |
| (Registrant) | |
| /s/ Reginald Averilla | |
| Reginald Averilla Chief Financial Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| Helena R. Santos | President, Chief Executive Officer, and Treasurer | March 31, 2025 |
| Reginald Averilla | Chief Financial Officer | March 31, 2025 |
| John A. Moore | Chairman of the Board | March 31, 2025 |
| Christopher Cox | Director | March 31, 2025 |
| Michael Blechman | Director | March 31, 2025 |
| Jurgen Schumacher | Director | March 31, 2025 |
| John Nicols | Director | March 31, 2025 |
SCIENTIFIC INDUSTRIES, INC. AND SUBSIDIARIES
CONTENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB firm ID 686) | F-2 |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB firm ID 339) | F-3 |
| Consolidated financial statements: | |
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Operations and Comprehensive Loss for the Year Ended December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Changes in Stockholders’ Equity for the Year Ended December 31, 2024 and 2023 | F-6 |
| Consolidated Statements of Cash Flows for the Year Ended December 31, 2024 and 2023 | F-7 |
| Notes to financial statements | F-8 – F-33 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.